Clinical trials
Astrocytoma trials in Switzerland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
31 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2002 | 2 |
| 2004 | 4 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2022 | 1 |
| 2023 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
| Recruiting | 5 |
| Active, not recruiting | 2 |
| Unknown status | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| European Organisation for Research and Treatment of Cancer - EORTC | 9 |
| Children's Oncology Group | 7 |
| Jasper Gerritsen | 2 |
| National Cancer Institute (NCI) | 2 |
| BeiGene USA, Inc. | 1 |
| Children's Hospital Los Angeles | 1 |
| Debiopharm International SA | 1 |
| Dr Andrea Rossetti | 1 |
| Erasmus Medical Center | 1 |
| Heidelberg University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Astrocytoma | 31 |
| Central Nervous System Neoplasms | 19 |
| Glioblastoma | 15 |
| Oligodendroglioma | 15 |
| Brain Neoplasms | 11 |
| Glioma | 10 |
| Gliosarcoma | 7 |
| Optic Nerve Glioma | 7 |
| Medulloblastoma | 6 |
| Choroid Plexus Neoplasms | 4 |
Trials
Showing 76 to 31 of 31. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.